Transcatheter Aortic Valve Implantation for Degenerated 19-mm Aortic Bioprosthetic Valve

Circ J. 2017 Dec 25;82(1):289-292. doi: 10.1253/circj.CJ-17-0851. Epub 2017 Nov 11.

Abstract

Background: The valve-in-valve procedure, in which a transcatheter heart valve (THV) is implanted over a prosthetic valve, has been shown to be safe and therapeutically effective, depending on the size of the replacement valve.Methods and Results:We report 3 cases of successful valve-in-valve procedure to replace a degenerated 19-mm stented prosthetic aortic valve. Balloon-expanding THVs were implanted: 20-mm in the 1st case and 23-mm in the next 2. Aortic stenosis was almost completely resolved in all patients, who recovered promptly and without cardiac adverse events.

Conclusions: Using the valve-in-valve procedure for a 19-mm degenerated bioprosthesis was feasible and safe.

Keywords: Degenerated bioprosthesis; Transcatheter aortic valve implantation; Valve-in-valve.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aortic Valve Insufficiency / therapy
  • Bioprosthesis*
  • Echocardiography
  • Female
  • Humans
  • Prosthesis Failure
  • Transcatheter Aortic Valve Replacement / instrumentation
  • Transcatheter Aortic Valve Replacement / methods*
  • Treatment Outcome